Unique Ingredient Identifier 30IQX730WE is listed as a ingredient substance
| RN | 25322-68-3 |
| NCIT | C84085 |
| RXCUI | 1314384 |
| MF | Polymer substance not supported |
UNII 30IQX730WE POLYETHYLENE GLYCOL 6000 is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL/SUBLINGUAL | TABLET | 70 MG |
| NASAL | IMPLANT | 675 UG |
| ORAL | CAPSULE | 462.5 MG |
| ORAL | CAPSULE, DELAYED ACTION | 4.43 MG |
| ORAL | CAPSULE, DELAYED RELEASE | 3.471 mg |
| ORAL | CAPSULE, EXTENDED RELEASE | 18.88 MG |
| ORAL | CAPSULE, HARD GELATIN | 450 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 17.46 MG |
| ORAL | TABLET | 36 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 3 MG |
| ORAL | TABLET, COATED | 40 MG |
| ORAL | TABLET, DELAYED ACTION | 2.5 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 1.14 MG |
| ORAL | TABLET, EXTENDED RELEASE | 86.4 MG |
| ORAL | TABLET, FILM COATED | 44 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 10 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 11.53 mg |
| ORAL | TABLET, SUSTAINED ACTION | 12.5 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 0.5 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 0.32 MG |
| RECTAL | SUPPOSITORY | 128 MG |
| TOPICAL | EMULSION, CREAM | 5 %W/W |
| TOPICAL | OINTMENT | NA |
| VAGINAL | INSERT | 0.1 MG |
| VAGINAL | TABLET | 3 MG |
| VAGINAL | TABLET, FILM COATED | 0.064 MG |